Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...
Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.
Hosted on MSN
What To Know About Metastatic Prostate Cancer
Metastatic prostate cancer is also referred to as stage 4 or advanced prostate cancer. It's cancer that began in the prostate, a gland located under the bladder of people assigned male at birth, and ...
The ArteraAI Prostate Test uses AI to analyze biopsy images, predicting hormone therapy benefits for prostate cancer patients. Approved in the US and UK, the test aids early diagnostic decisions, ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...
Life-extending prostate cancer drug to be made available to thousands more patients - Men with high-risk prostate cancer that has not yet spread now qualify for the treatment ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results